RS63273B1 - Kompozicije koje sadrže bakterijski soj - Google Patents
Kompozicije koje sadrže bakterijski sojInfo
- Publication number
- RS63273B1 RS63273B1 RS20220465A RSP20220465A RS63273B1 RS 63273 B1 RS63273 B1 RS 63273B1 RS 20220465 A RS20220465 A RS 20220465A RS P20220465 A RSP20220465 A RS P20220465A RS 63273 B1 RS63273 B1 RS 63273B1
- Authority
- RS
- Serbia
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pediatric Medicine (AREA)
- Physiology (AREA)
- General Engineering & Computer Science (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18171893 | 2018-05-11 | ||
EP18178136 | 2018-06-15 | ||
GBGB1810386.1A GB201810386D0 (en) | 2018-06-25 | 2018-06-25 | Compositions comprising bacterial strains |
GBGB1813460.1A GB201813460D0 (en) | 2018-08-17 | 2018-08-17 | Compositions comprising bacterial strains |
GBGB1817642.0A GB201817642D0 (en) | 2018-10-29 | 2018-10-29 | Compositions comprising bacterial strains |
GBGB1820264.8A GB201820264D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
GBGB1820256.4A GB201820256D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
PCT/EP2019/062238 WO2019215346A1 (en) | 2018-05-11 | 2019-05-13 | Compositions comprising bacterial strains |
EP19725068.1A EP3743086B1 (en) | 2018-05-11 | 2019-05-13 | Compositions comprising bacterial strains |
Publications (1)
Publication Number | Publication Date |
---|---|
RS63273B1 true RS63273B1 (sr) | 2022-06-30 |
Family
ID=66597549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20220465A RS63273B1 (sr) | 2018-05-11 | 2019-05-13 | Kompozicije koje sadrže bakterijski soj |
Country Status (22)
Country | Link |
---|---|
US (3) | US11419902B2 (sr) |
EP (4) | EP3790564A1 (sr) |
JP (3) | JP7058449B2 (sr) |
KR (2) | KR20210008391A (sr) |
CN (2) | CN112601534A (sr) |
AU (3) | AU2019267170A1 (sr) |
BR (1) | BR112020022833A2 (sr) |
CA (2) | CA3098971A1 (sr) |
CY (1) | CY1125211T1 (sr) |
DK (1) | DK3743086T3 (sr) |
ES (1) | ES2916601T3 (sr) |
HR (1) | HRP20220578T1 (sr) |
IL (1) | IL278471B2 (sr) |
LT (1) | LT3743086T (sr) |
MD (1) | MD3743086T2 (sr) |
MX (1) | MX2020012061A (sr) |
PL (1) | PL3743086T3 (sr) |
RS (1) | RS63273B1 (sr) |
SG (2) | SG11202011031UA (sr) |
SI (1) | SI3743086T1 (sr) |
TW (2) | TW202011975A (sr) |
WO (2) | WO2019215346A1 (sr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019015792A8 (pt) | 2017-01-31 | 2023-01-03 | Univ Kansas State | Células microbianas, métodos de sua produção e usos destas |
CN111032061A (zh) | 2017-06-14 | 2020-04-17 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
US11814617B2 (en) | 2017-10-20 | 2023-11-14 | Kansas State University Research Foundation | Methods of producing ensiled plant materials using Megasphaera elsdenii |
PL3743086T3 (pl) * | 2018-05-11 | 2022-06-20 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
JP2022511975A (ja) * | 2018-12-12 | 2022-02-01 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
TW202216178A (zh) * | 2020-06-11 | 2022-05-01 | 美商艾弗洛生物科技股份有限公司 | 使用巨型球菌屬物種治療疾病及障礙之組成物及方法 |
CN112980878B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac8基因敲除的bhk-21细胞系及其构建方法和应用 |
CN112877275B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac2基因敲除的bhk-21细胞系及其构建方法和应用 |
KR102551061B1 (ko) * | 2022-05-26 | 2023-07-03 | 중앙대학교 산학협력단 | Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5557520A (en) * | 1978-10-26 | 1980-04-28 | Nisshin Flour Milling Co Ltd | Preparation of carcinostatic substance |
WO2002080947A1 (fr) * | 2001-04-06 | 2002-10-17 | Kyodoken Institute For Animal Science Research & Development | Compositions contenant une bacterie pouvant convertir de l'acide lactique en acide butyrique, et methode utilisant ces compositions pour prevenir ou traiter l'hyperlactacidemie dans le systeme digestif ou le cancer du colon |
GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
US20040005304A1 (en) | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
GB0307026D0 (en) * | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
EP2226072A1 (en) | 2003-08-29 | 2010-09-08 | Aton Pharma, Inc. | Combinations of suberoylanilide hydroxamic acid and antimetbolic agents for treating cancer |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
EP2953472A4 (en) | 2012-11-23 | 2017-03-01 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
EP3021853A1 (en) * | 2013-07-18 | 2016-05-25 | Baylor College Of Medicine | Method of enhancing potency of immune cells |
CN104415060A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
WO2015038731A1 (en) | 2013-09-12 | 2015-03-19 | The Johns Hopkins University | Biofilm formation to define risk for colon cancer |
MX367109B (es) | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
US9650654B2 (en) * | 2014-06-25 | 2017-05-16 | William Marsh Rice University | Making C4+ products in bacteria |
US10366793B2 (en) * | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
WO2016073381A1 (en) * | 2014-11-03 | 2016-05-12 | Cerus Corporation | Compositions and methods for improved car-t cell therapies |
MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
CA2974510A1 (en) * | 2015-01-23 | 2016-07-28 | Temple University-Of The Commonwealth System Of Higher Education | Use of short chain fatty acids in cancer prevention |
WO2016149449A1 (en) | 2015-03-18 | 2016-09-22 | Tufts University | Compositions and methods for preventing colorectal cancer |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
LT3209310T (lt) * | 2015-11-20 | 2018-04-25 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterinius kamienus |
PT3380108T (pt) * | 2015-11-24 | 2023-02-17 | Seres Therapeutics Inc | Composições bacterianas concebidas |
EP3402872A4 (en) * | 2016-01-11 | 2019-06-12 | 3PLW Ltd. | BACTERIA USING LACTIC ACID, GENETICALLY MODIFIED TO SECURE ENZYMES DEGRADING POLYSACCHARIDES |
CN107028985A (zh) * | 2016-02-04 | 2017-08-11 | 深圳华大基因研究院 | 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用 |
US20190125808A1 (en) * | 2016-03-30 | 2019-05-02 | The Trustees Of Columbia University In The City Of New York | Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria |
US9999641B2 (en) * | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
MX2019003447A (es) * | 2016-09-27 | 2019-08-29 | Univ Texas | Metodos para mejorar la terapia de bloqueo del punto de control inmune mediante la modulacion del microbioma. |
US11571446B2 (en) | 2016-11-18 | 2023-02-07 | Sanford Bumham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
WO2018112365A2 (en) | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii |
WO2018112363A1 (en) | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating cancer using parabacteroides |
CN111032061A (zh) | 2017-06-14 | 2020-04-17 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
CN111107859B (zh) * | 2017-06-14 | 2022-04-29 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
PL3743086T3 (pl) | 2018-05-11 | 2022-06-20 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
CA3122338A1 (en) | 2018-12-12 | 2020-06-18 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
-
2019
- 2019-05-13 PL PL19725068T patent/PL3743086T3/pl unknown
- 2019-05-13 WO PCT/EP2019/062238 patent/WO2019215346A1/en active Search and Examination
- 2019-05-13 ES ES19725068T patent/ES2916601T3/es active Active
- 2019-05-13 TW TW108116469A patent/TW202011975A/zh unknown
- 2019-05-13 LT LTEPPCT/EP2019/062238T patent/LT3743086T/lt unknown
- 2019-05-13 MX MX2020012061A patent/MX2020012061A/es unknown
- 2019-05-13 SG SG11202011031UA patent/SG11202011031UA/en unknown
- 2019-05-13 EP EP19725067.3A patent/EP3790564A1/en not_active Withdrawn
- 2019-05-13 EP EP22162425.7A patent/EP4066845A1/en active Pending
- 2019-05-13 RS RS20220465A patent/RS63273B1/sr unknown
- 2019-05-13 AU AU2019267170A patent/AU2019267170A1/en not_active Abandoned
- 2019-05-13 CN CN201980031147.8A patent/CN112601534A/zh active Pending
- 2019-05-13 BR BR112020022833-8A patent/BR112020022833A2/pt unknown
- 2019-05-13 MD MDE20201221T patent/MD3743086T2/ro unknown
- 2019-05-13 EP EP19725068.1A patent/EP3743086B1/en active Active
- 2019-05-13 CA CA3098971A patent/CA3098971A1/en active Pending
- 2019-05-13 JP JP2020545563A patent/JP7058449B2/ja active Active
- 2019-05-13 SG SG11202011028SA patent/SG11202011028SA/en unknown
- 2019-05-13 WO PCT/EP2019/062236 patent/WO2019215345A1/en active Search and Examination
- 2019-05-13 TW TW108116449A patent/TW202014513A/zh unknown
- 2019-05-13 KR KR1020207035242A patent/KR20210008391A/ko not_active Application Discontinuation
- 2019-05-13 CA CA3099209A patent/CA3099209A1/en active Pending
- 2019-05-13 CN CN201980031512.5A patent/CN112512539A/zh active Pending
- 2019-05-13 JP JP2020562128A patent/JP2021523895A/ja active Pending
- 2019-05-13 AU AU2019267171A patent/AU2019267171A1/en not_active Abandoned
- 2019-05-13 KR KR1020207035244A patent/KR20210008393A/ko unknown
- 2019-05-13 HR HRP20220578TT patent/HRP20220578T1/hr unknown
- 2019-05-13 EP EP22162255.8A patent/EP4056192A1/en active Pending
- 2019-05-13 SI SI201930216T patent/SI3743086T1/sl unknown
- 2019-05-13 DK DK19725068.1T patent/DK3743086T3/da active
-
2020
- 2020-09-04 US US17/013,026 patent/US11419902B2/en active Active
- 2020-11-03 IL IL278471A patent/IL278471B2/en unknown
- 2020-11-11 US US17/095,427 patent/US20210275605A1/en not_active Abandoned
-
2022
- 2022-04-05 JP JP2022062741A patent/JP2022088631A/ja active Pending
- 2022-05-27 CY CY20221100367T patent/CY1125211T1/el unknown
- 2022-06-23 US US17/847,336 patent/US20230158083A1/en not_active Abandoned
-
2023
- 2023-02-03 AU AU2023200562A patent/AU2023200562A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283751A (en) | Compositions comprising bacterial strains | |
SG11202011028SA (en) | Compositions comprising bacterial strains | |
IL277422A (en) | compounds containing bacterial strains | |
IL281951A (en) | compounds containing bacterial strains | |
IL280895A (en) | compounds containing bacterial strains | |
IL279963A (en) | compounds containing bacterial strains | |
IL279339A (en) | compounds containing bacterial strains | |
IL282439A (en) | compounds containing bacterial strains | |
IL279724B (en) | compounds containing bacterial strains | |
PT3723777T (pt) | Composições que compreendem estirpes bacterianas | |
PT3743086T (pt) | Composições compreendendo estirpes bacterianas | |
GB201820744D0 (en) | Compositions comprising bacterial strains | |
GB201820745D0 (en) | Compositions comprising bacterial strains | |
GB201820230D0 (en) | Compositions comprising bacterial strains | |
GB201820256D0 (en) | Compositions comprising bacterial strains | |
GB201820261D0 (en) | Compositions comprising bacterial strains | |
GB201820264D0 (en) | Compositions comprising bacterial strains | |
GB201817641D0 (en) | Compositions comprising bacterial strains | |
GB201817642D0 (en) | Compositions comprising bacterial strains | |
GB201817648D0 (en) | Compositions comprising bacterial strains | |
GB201814836D0 (en) | Compositions comprising bacterial strains | |
GB201813423D0 (en) | Compositions comprising bacterial strains | |
GB201813460D0 (en) | Compositions comprising bacterial strains | |
GB201812378D0 (en) | Compositions comprising bacterial strains | |
GB201811900D0 (en) | Compositions comprising bacterial strains |